# 2025-19062: Mississippi Nurse Denied Drug Prescribing Privileges by DEA

2025-19062, Jody Adams, N.P.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-09-30, effective 2025-10-30 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19062
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19062
- Title: Jody Adams, N.P.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 46921
- Published: 2025-09-30
- Effective: 2025-10-30
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Mississippi Nurse Denied Drug Prescribing Privileges by DEA

## Summary

Jody Adams, a nurse practitioner from Mississippi, tried to get a DEA registration but got denied because she issued three controlled substance prescriptions without proper authorization. This decision means she can’t legally prescribe these drugs, protecting public safety. The denial is final, and no hearing was requested, so the decision is effective immediately with no money penalties mentioned.

## Effects PRIA read

- DEA Registration Denied for Jody Adams: cost, high. The Drug Enforcement Administration denied the DEA registration application (Control No. W24008696M) of Jody Adams, N.P., and also denied any other pending registration application of hers in Mississippi. The record shows she admitted issuing three controlled-substance prescriptions without an acti…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19062 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/30/2025-19062/jody-adams-np-decision-and-order)
- [2025-19062 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-30/pdf/2025-19062.pdf)

## Related
- [Previous: 2025-19061, Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing and Immediate…](https://policyrisk.com/federal-register/2025-19061)
- [Next: 2025-19064, Self-Regulatory Organizations; National Securities Clearing Corporation; Notice…](https://policyrisk.com/federal-register/2025-19064)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19062 (as of 2026-06-08).
